JPS59210897A - Production of beta-lactam compound - Google Patents
Production of beta-lactam compoundInfo
- Publication number
- JPS59210897A JPS59210897A JP58086182A JP8618283A JPS59210897A JP S59210897 A JPS59210897 A JP S59210897A JP 58086182 A JP58086182 A JP 58086182A JP 8618283 A JP8618283 A JP 8618283A JP S59210897 A JPS59210897 A JP S59210897A
- Authority
- JP
- Japan
- Prior art keywords
- compound
- culture
- tan
- spirillum
- antibiotic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000004519 manufacturing process Methods 0.000 title claims description 9
- -1 beta-lactam compound Chemical class 0.000 title description 13
- 241000605008 Spirillum Species 0.000 claims abstract description 12
- 150000003839 salts Chemical class 0.000 claims abstract description 12
- 244000005700 microbiome Species 0.000 claims abstract description 7
- 150000001875 compounds Chemical class 0.000 claims description 20
- 238000012258 culturing Methods 0.000 claims description 7
- 239000001963 growth medium Substances 0.000 claims description 2
- 241000894006 Bacteria Species 0.000 abstract description 13
- BSIMZHVOQZIAOY-SCSAIBSYSA-N 1-carbapenem-3-carboxylic acid Chemical compound OC(=O)C1=CC[C@@H]2CC(=O)N12 BSIMZHVOQZIAOY-SCSAIBSYSA-N 0.000 abstract description 6
- 239000000203 mixture Substances 0.000 abstract description 5
- 239000003814 drug Substances 0.000 abstract description 3
- 230000000844 anti-bacterial effect Effects 0.000 abstract description 2
- 239000003782 beta lactam antibiotic agent Substances 0.000 abstract description 2
- 239000003153 chemical reaction reagent Substances 0.000 abstract description 2
- 229940079593 drug Drugs 0.000 abstract description 2
- 239000000706 filtrate Substances 0.000 abstract description 2
- 238000002360 preparation method Methods 0.000 abstract description 2
- 239000002132 β-lactam antibiotic Substances 0.000 abstract description 2
- 229940124586 β-lactam antibiotics Drugs 0.000 abstract description 2
- 239000000463 material Substances 0.000 abstract 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 17
- FVAUCKIRQBBSSJ-UHFFFAOYSA-M sodium iodide Chemical compound [Na+].[I-] FVAUCKIRQBBSSJ-UHFFFAOYSA-M 0.000 description 12
- 239000000243 solution Substances 0.000 description 12
- 238000004587 chromatography analysis Methods 0.000 description 11
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 11
- 238000000034 method Methods 0.000 description 10
- 159000000000 sodium salts Chemical class 0.000 description 10
- 239000000126 substance Substances 0.000 description 10
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 9
- 230000003115 biocidal effect Effects 0.000 description 9
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 8
- 239000007864 aqueous solution Substances 0.000 description 8
- 239000002609 medium Substances 0.000 description 8
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 6
- 239000003242 anti bacterial agent Substances 0.000 description 6
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
- 229940088710 antibiotic agent Drugs 0.000 description 5
- 235000013372 meat Nutrition 0.000 description 5
- 239000011780 sodium chloride Substances 0.000 description 5
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- 239000002253 acid Substances 0.000 description 4
- 239000012141 concentrate Substances 0.000 description 4
- 239000000284 extract Substances 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- JHJLBTNAGRQEKS-UHFFFAOYSA-M sodium bromide Chemical compound [Na+].[Br-] JHJLBTNAGRQEKS-UHFFFAOYSA-M 0.000 description 4
- 235000009518 sodium iodide Nutrition 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 238000000862 absorption spectrum Methods 0.000 description 3
- 238000001142 circular dichroism spectrum Methods 0.000 description 3
- 238000004440 column chromatography Methods 0.000 description 3
- 239000008103 glucose Substances 0.000 description 3
- 230000012010 growth Effects 0.000 description 3
- 238000004128 high performance liquid chromatography Methods 0.000 description 3
- 239000002808 molecular sieve Substances 0.000 description 3
- NLKNQRATVPKPDG-UHFFFAOYSA-M potassium iodide Chemical compound [K+].[I-] NLKNQRATVPKPDG-UHFFFAOYSA-M 0.000 description 3
- 230000002829 reductive effect Effects 0.000 description 3
- 239000011347 resin Substances 0.000 description 3
- 229920005989 resin Polymers 0.000 description 3
- URGAHOPLAPQHLN-UHFFFAOYSA-N sodium aluminosilicate Chemical compound [Na+].[Al+3].[O-][Si]([O-])=O.[O-][Si]([O-])=O URGAHOPLAPQHLN-UHFFFAOYSA-N 0.000 description 3
- 238000001228 spectrum Methods 0.000 description 3
- 150000003464 sulfur compounds Chemical class 0.000 description 3
- 239000006228 supernatant Substances 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- 229920001817 Agar Polymers 0.000 description 2
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 2
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- 244000068988 Glycine max Species 0.000 description 2
- 235000010469 Glycine max Nutrition 0.000 description 2
- SIKJAQJRHWYJAI-UHFFFAOYSA-N Indole Chemical compound C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 2
- 229920005654 Sephadex Polymers 0.000 description 2
- 239000012507 Sephadex™ Substances 0.000 description 2
- 240000008042 Zea mays Species 0.000 description 2
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 2
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 2
- 230000002378 acidificating effect Effects 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- 239000013543 active substance Substances 0.000 description 2
- 239000008272 agar Substances 0.000 description 2
- 238000013019 agitation Methods 0.000 description 2
- 229910052783 alkali metal Inorganic materials 0.000 description 2
- 229910001508 alkali metal halide Inorganic materials 0.000 description 2
- 150000008045 alkali metal halides Chemical class 0.000 description 2
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 2
- 229910001615 alkaline earth metal halide Inorganic materials 0.000 description 2
- 235000011114 ammonium hydroxide Nutrition 0.000 description 2
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 2
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 2
- 235000011130 ammonium sulphate Nutrition 0.000 description 2
- 230000004071 biological effect Effects 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 239000001913 cellulose Substances 0.000 description 2
- 238000002983 circular dichroism Methods 0.000 description 2
- 235000005822 corn Nutrition 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 235000013312 flour Nutrition 0.000 description 2
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 2
- 150000008282 halocarbons Chemical class 0.000 description 2
- 238000009630 liquid culture Methods 0.000 description 2
- CEQFOVLGLXCDCX-WUKNDPDISA-N methyl red Chemical compound C1=CC(N(C)C)=CC=C1\N=N\C1=CC=CC=C1C(O)=O CEQFOVLGLXCDCX-WUKNDPDISA-N 0.000 description 2
- XKBGEWXEAPTVCK-UHFFFAOYSA-M methyltrioctylammonium chloride Chemical compound [Cl-].CCCCCCCC[N+](C)(CCCCCCCC)CCCCCCCC XKBGEWXEAPTVCK-UHFFFAOYSA-M 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 230000001590 oxidative effect Effects 0.000 description 2
- 239000000049 pigment Substances 0.000 description 2
- IOLCXVTUBQKXJR-UHFFFAOYSA-M potassium bromide Chemical compound [K+].[Br-] IOLCXVTUBQKXJR-UHFFFAOYSA-M 0.000 description 2
- FGIUAXJPYTZDNR-UHFFFAOYSA-N potassium nitrate Chemical compound [K+].[O-][N+]([O-])=O FGIUAXJPYTZDNR-UHFFFAOYSA-N 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 239000002689 soil Substances 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- LWIHDJKSTIGBAC-UHFFFAOYSA-K tripotassium phosphate Chemical compound [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 2
- UAYWVJHJZHQCIE-UHFFFAOYSA-L zinc iodide Chemical compound I[Zn]I UAYWVJHJZHQCIE-UHFFFAOYSA-L 0.000 description 2
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- PAWQVTBBRAZDMG-UHFFFAOYSA-N 2-(3-bromo-2-fluorophenyl)acetic acid Chemical compound OC(=O)CC1=CC=CC(Br)=C1F PAWQVTBBRAZDMG-UHFFFAOYSA-N 0.000 description 1
- WTLKTXIHIHFSGU-UHFFFAOYSA-N 2-nitrosoguanidine Chemical compound NC(N)=NN=O WTLKTXIHIHFSGU-UHFFFAOYSA-N 0.000 description 1
- 239000004254 Ammonium phosphate Substances 0.000 description 1
- 241000272517 Anseriformes Species 0.000 description 1
- VQWNGCSUNKJFLW-ACPVBGRSSA-N Antibiotic TA Chemical compound CCCC1OC(=O)C(C)CC(C)CCCCC(=O)CCCC(CC)\C=C\C=C(COC)\CCC(O)C(O)CC(O)CNC1=O VQWNGCSUNKJFLW-ACPVBGRSSA-N 0.000 description 1
- 208000035143 Bacterial infection Diseases 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- UNMYWSMUMWPJLR-UHFFFAOYSA-L Calcium iodide Chemical compound [Ca+2].[I-].[I-] UNMYWSMUMWPJLR-UHFFFAOYSA-L 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
- 239000005973 Carvone Substances 0.000 description 1
- 102000016938 Catalase Human genes 0.000 description 1
- 108010053835 Catalase Proteins 0.000 description 1
- 241001327708 Coriaria sarmentosa Species 0.000 description 1
- RGHNJXZEOKUKBD-UHFFFAOYSA-N D-gluconic acid Natural products OCC(O)C(O)C(O)C(O)C(O)=O RGHNJXZEOKUKBD-UHFFFAOYSA-N 0.000 description 1
- PQUCIEFHOVEZAU-UHFFFAOYSA-N Diammonium sulfite Chemical compound [NH4+].[NH4+].[O-]S([O-])=O PQUCIEFHOVEZAU-UHFFFAOYSA-N 0.000 description 1
- RWSOTUBLDIXVET-UHFFFAOYSA-N Dihydrogen sulfide Chemical compound S RWSOTUBLDIXVET-UHFFFAOYSA-N 0.000 description 1
- 241000588698 Erwinia Species 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 241000192125 Firmicutes Species 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- RGHNJXZEOKUKBD-SQOUGZDYSA-N Gluconic acid Natural products OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 description 1
- 108010024636 Glutathione Proteins 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 241000234435 Lilium Species 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 240000000249 Morus alba Species 0.000 description 1
- 235000008708 Morus alba Nutrition 0.000 description 1
- GXCLVBGFBYZDAG-UHFFFAOYSA-N N-[2-(1H-indol-3-yl)ethyl]-N-methylprop-2-en-1-amine Chemical compound CN(CCC1=CNC2=C1C=CC=C2)CC=C GXCLVBGFBYZDAG-UHFFFAOYSA-N 0.000 description 1
- 229910002651 NO3 Inorganic materials 0.000 description 1
- NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 description 1
- 241000233855 Orchidaceae Species 0.000 description 1
- 102000004316 Oxidoreductases Human genes 0.000 description 1
- 108090000854 Oxidoreductases Proteins 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 239000001888 Peptone Substances 0.000 description 1
- 108010080698 Peptones Proteins 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 241001474791 Proboscis Species 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 241000607720 Serratia Species 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- CCAZWUJBLXKBAY-ULZPOIKGSA-N Tutin Chemical compound C([C@]12[C@@H]3O[C@@H]3[C@@]3(O)[C@H]4C(=O)O[C@@H]([C@H]([C@]32C)O)[C@H]4C(=C)C)O1 CCAZWUJBLXKBAY-ULZPOIKGSA-N 0.000 description 1
- 229930003270 Vitamin B Natural products 0.000 description 1
- FZNCGRZWXLXZSZ-CIQUZCHMSA-N Voglibose Chemical compound OCC(CO)N[C@H]1C[C@](O)(CO)[C@@H](O)[C@H](O)[C@H]1O FZNCGRZWXLXZSZ-CIQUZCHMSA-N 0.000 description 1
- 239000002250 absorbent Substances 0.000 description 1
- 230000002745 absorbent Effects 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 238000001467 acupuncture Methods 0.000 description 1
- 239000003463 adsorbent Substances 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 235000019270 ammonium chloride Nutrition 0.000 description 1
- 229910000148 ammonium phosphate Inorganic materials 0.000 description 1
- 235000019289 ammonium phosphates Nutrition 0.000 description 1
- 150000003863 ammonium salts Chemical class 0.000 description 1
- 238000005349 anion exchange Methods 0.000 description 1
- 239000003957 anion exchange resin Substances 0.000 description 1
- 150000001450 anions Chemical class 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 239000002518 antifoaming agent Substances 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 208000022362 bacterial infectious disease Diseases 0.000 description 1
- 238000003287 bathing Methods 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- 229910001622 calcium bromide Inorganic materials 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- WGEFECGEFUFIQW-UHFFFAOYSA-L calcium dibromide Chemical compound [Ca+2].[Br-].[Br-] WGEFECGEFUFIQW-UHFFFAOYSA-L 0.000 description 1
- 229910001640 calcium iodide Inorganic materials 0.000 description 1
- 229940046413 calcium iodide Drugs 0.000 description 1
- 229940041514 candida albicans extract Drugs 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 235000010980 cellulose Nutrition 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- SXPWTBGAZSPLHA-UHFFFAOYSA-M cetalkonium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCC[N+](C)(C)CC1=CC=CC=C1 SXPWTBGAZSPLHA-UHFFFAOYSA-M 0.000 description 1
- 229920001429 chelating resin Polymers 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 235000013330 chicken meat Nutrition 0.000 description 1
- 210000000078 claw Anatomy 0.000 description 1
- GVPFVAHMJGGAJG-UHFFFAOYSA-L cobalt dichloride Chemical compound [Cl-].[Cl-].[Co+2] GVPFVAHMJGGAJG-UHFFFAOYSA-L 0.000 description 1
- 229910000365 copper sulfate Inorganic materials 0.000 description 1
- ARUVKPQLZAKDPS-UHFFFAOYSA-L copper(II) sulfate Chemical compound [Cu+2].[O-][S+2]([O-])([O-])[O-] ARUVKPQLZAKDPS-UHFFFAOYSA-L 0.000 description 1
- LAQCZBYXNRANFU-PMKNNYEISA-N crotocin Chemical compound CC1([C@@]2(C)[C@H]3O[C@H]3C(C)=C[C@H]2O[C@@H]2C[C@H]1OC(=O)\C=C/C)[C@]21CO1 LAQCZBYXNRANFU-PMKNNYEISA-N 0.000 description 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
- 235000018417 cysteine Nutrition 0.000 description 1
- 238000011033 desalting Methods 0.000 description 1
- MNNHAPBLZZVQHP-UHFFFAOYSA-N diammonium hydrogen phosphate Chemical compound [NH4+].[NH4+].OP([O-])([O-])=O MNNHAPBLZZVQHP-UHFFFAOYSA-N 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 125000000118 dimethyl group Chemical group [H]C([H])([H])* 0.000 description 1
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 description 1
- 235000019800 disodium phosphate Nutrition 0.000 description 1
- 229910000397 disodium phosphate Inorganic materials 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 239000011790 ferrous sulphate Substances 0.000 description 1
- 235000003891 ferrous sulphate Nutrition 0.000 description 1
- 230000028564 filamentous growth Effects 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 210000003495 flagella Anatomy 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 230000000855 fungicidal effect Effects 0.000 description 1
- 239000000417 fungicide Substances 0.000 description 1
- 239000000174 gluconic acid Substances 0.000 description 1
- 235000012208 gluconic acid Nutrition 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- 229960003180 glutathione Drugs 0.000 description 1
- 230000009422 growth inhibiting effect Effects 0.000 description 1
- 229910000037 hydrogen sulfide Inorganic materials 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxide Chemical compound [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 description 1
- VVIUBCNYACGLLV-UHFFFAOYSA-N hypotaurine Chemical compound [NH3+]CCS([O-])=O VVIUBCNYACGLLV-UHFFFAOYSA-N 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- PZOUSPYUWWUPPK-UHFFFAOYSA-N indole Natural products CC1=CC=CC2=C1C=CN2 PZOUSPYUWWUPPK-UHFFFAOYSA-N 0.000 description 1
- RKJUIXBNRJVNHR-UHFFFAOYSA-N indolenine Natural products C1=CC=C2CC=NC2=C1 RKJUIXBNRJVNHR-UHFFFAOYSA-N 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 230000035987 intoxication Effects 0.000 description 1
- 231100000566 intoxication Toxicity 0.000 description 1
- BAUYGSIQEAFULO-UHFFFAOYSA-L iron(2+) sulfate (anhydrous) Chemical compound [Fe+2].[O-]S([O-])(=O)=O BAUYGSIQEAFULO-UHFFFAOYSA-L 0.000 description 1
- 229910000359 iron(II) sulfate Inorganic materials 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 244000144972 livestock Species 0.000 description 1
- OTCKOJUMXQWKQG-UHFFFAOYSA-L magnesium bromide Chemical compound [Mg+2].[Br-].[Br-] OTCKOJUMXQWKQG-UHFFFAOYSA-L 0.000 description 1
- 229910001623 magnesium bromide Inorganic materials 0.000 description 1
- BLQJIBCZHWBKSL-UHFFFAOYSA-L magnesium iodide Chemical compound [Mg+2].[I-].[I-] BLQJIBCZHWBKSL-UHFFFAOYSA-L 0.000 description 1
- 229910001641 magnesium iodide Inorganic materials 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 235000013379 molasses Nutrition 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 238000000655 nuclear magnetic resonance spectrum Methods 0.000 description 1
- 239000006916 nutrient agar Substances 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 235000014593 oils and fats Nutrition 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 150000002898 organic sulfur compounds Chemical class 0.000 description 1
- FECKHSTWGKTQAN-UHFFFAOYSA-N pentan-1-amine;hydrobromide Chemical compound [Br-].CCCCC[NH3+] FECKHSTWGKTQAN-UHFFFAOYSA-N 0.000 description 1
- 235000019319 peptone Nutrition 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 229920001467 poly(styrenesulfonates) Polymers 0.000 description 1
- 229920001521 polyalkylene glycol ether Polymers 0.000 description 1
- 239000001103 potassium chloride Substances 0.000 description 1
- 235000011164 potassium chloride Nutrition 0.000 description 1
- 235000010333 potassium nitrate Nutrition 0.000 description 1
- 239000004323 potassium nitrate Substances 0.000 description 1
- 229910000160 potassium phosphate Inorganic materials 0.000 description 1
- 235000011009 potassium phosphates Nutrition 0.000 description 1
- 235000019814 powdered cellulose Nutrition 0.000 description 1
- 229920003124 powdered cellulose Polymers 0.000 description 1
- 238000002953 preparative HPLC Methods 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- KCXFHTAICRTXLI-UHFFFAOYSA-N propane-1-sulfonic acid Chemical compound CCCS(O)(=O)=O KCXFHTAICRTXLI-UHFFFAOYSA-N 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 229920002545 silicone oil Polymers 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000001488 sodium phosphate Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 239000003549 soybean oil Substances 0.000 description 1
- 235000012424 soybean oil Nutrition 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 230000003068 static effect Effects 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 210000001179 synovial fluid Anatomy 0.000 description 1
- VDZOOKBUILJEDG-UHFFFAOYSA-M tetrabutylammonium hydroxide Chemical compound [OH-].CCCC[N+](CCCC)(CCCC)CCCC VDZOOKBUILJEDG-UHFFFAOYSA-M 0.000 description 1
- 229940124597 therapeutic agent Drugs 0.000 description 1
- DHCDFWKWKRSZHF-UHFFFAOYSA-L thiosulfate(2-) Chemical compound [O-]S([S-])(=O)=O DHCDFWKWKRSZHF-UHFFFAOYSA-L 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- 239000003021 water soluble solvent Substances 0.000 description 1
- 239000012138 yeast extract Substances 0.000 description 1
Landscapes
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
Description
【発明の詳細な説明】
本発明は新規抗生物質T A、 pr −458および
その塩の製造法に関する。DETAILED DESCRIPTION OF THE INVENTION The present invention relates to a method for producing a novel antibiotic TA, pr-458, and its salts.
木究明者らは、新規な抗生物質の探索を目的として多数
の微生物を土壌より分bib L、その産生ずる抗生物
質全分離探索したところ、ある種の微生物がβ−ラクク
ダム化合物である抗生物質’I’AN−458を産生ず
ること、該微生物がスピリルム属に属すること、該微生
物を適宜の培地に培養することによってグラム陽性細菌
およびダラム陰性細菌に対して抗菌力を示す抗生物質を
培地中に蓄積しうろことなどを知り、この抗生物質を単
離し、その物理化学的および生物学的諸性質から、当該
抗生物質が下式で表わされるβ−ラクタム抗生物質であ
ることを確めた。In order to search for new antibiotics, researchers isolated a large number of microorganisms from the soil and searched for all the antibiotics they produced. The microorganism belongs to the genus Spirillum, and by culturing the microorganism in an appropriate medium, an antibiotic that exhibits antibacterial activity against Gram-positive bacteria and Durum-negative bacteria is added to the medium. After learning about the accumulation of scales, we isolated this antibiotic and confirmed from its physicochemical and biological properties that it was a β-lactam antibiotic represented by the following formula.
該(1合物は既にり、D、 Cama らによって合
成されているが(J、Amer、 Chem、 Soc
、 100 + 8006(+978))、該化合物(
ナトリウム塩)が不安定なため物理化学的諸性質が明確
に記載されていない。また、W、L、 Parkerら
は該化合物(遊呼カルボン酸)を5Q27860と称し
、p−ニトロベンジルエステルに誘導化後、セラシア(
Serratia )Mおよび工μヴイニャ(Erwi
nia )FA菌の代鞠産物として培養gIから単離し
ている( J、 Antibiotics 、 35.
653 (1982))。The first compound has already been synthesized by D. Cama et al. (J. Amer. Chem. Soc.
, 100 + 8006 (+978)), the compound (
Because the sodium salt) is unstable, its physicochemical properties are not clearly described. In addition, W, L, Parker et al. named this compound (free carboxylic acid) as 5Q27860, and after derivatizing it to p-nitrobenzyl ester, it was converted to Serasia (
Serratia) M and Erwi
nia) has been isolated from cultured gI as a substitute product of FA bacteria (J, Antibiotics, 35.
653 (1982)).
この場合も化合物(I)を培養欣中から単離することは
不可能で従って物理化学的諸性質の記載はされていない
。In this case as well, it is impossible to isolate compound (I) from the culture medium, and therefore its physicochemical properties are not described.
本発明者らは、これらの知見を認識したうえでさらに研
究を重ねた結果本発明を完成した。The present inventors recognized these findings and completed the present invention as a result of further research.
すなわち、本発明はスピリルム広すに属する式(
で示される化合物の生産菌を培地に培養し、培養物中に
上式の化合物全生成蓄積せしめ、これを採取することを
特徴とする上式の化合物またはその塩の製造法て゛める
。That is, the present invention provides a method for producing a compound of the above formula, which is characterized by culturing in a medium a bacterium that produces a compound of the formula ( Learn about methods for producing compounds or their salts.
なお、本願では抗生物質T A xq −458全単に
T A N −458と称することもある。In addition, in this application, the antibiotic T A xq -458 may be simply referred to as T A N -458.
本発明で使用される抗生物γ′f T AN −458
生並酌としては、スピリルム(Spirilllum)
属に属し、抗生物質T A N −458を産生ずる能
力を何するものであれば如何なる1)孜生物でもよい。Antibiotic γ′f T AN-458 used in the present invention
Spirillum (Spirillum) is used as a raw sake.
1) Any species may be used as long as it belongs to the genus and has the ability to produce the antibiotic TAN-458.
抗生物質TAN−458生産菌の例としては、たとえば
本発明者らによって兵庫県の土壌より採取したスピリル
ム(Spirillum’)属のUK 1521株(
以下、rUK−1521株」と略称することもある。)
があげられる。ヌビリμム属のUK−1521株の菌学
的性状は下記のとおシである。As an example of antibiotic TAN-458-producing bacteria, UK 1521 strain of the genus Spirillum (Spirillum') collected from soil in Hyogo Prefecture by the present inventors is used.
Hereinafter, it may be abbreviated as "rUK-1521 strain". )
can be given. The mycological properties of UK-1521 strain of the genus Nubilium are as follows.
(a)形 態
肉汁寒天斜面上で2El、2日間培養後の観察では、剖
胞は幅0.6〜0.9μ、長さ2.5〜12μのカーブ
ないしラセン状で、多形性を示さない。(a) Morphology Observation after culturing for 2 days on a broth agar slant at 2El showed that the necrocysts were curved or spiral-shaped with a width of 0.6-0.9μ and a length of 2.5-12μ, with pleomorphism. Not shown.
jIル動性があシ、極鞭毛を有する。胞子を形成せず、
またグフム染色は陰性で、抗酸性を示さない。It is mobile and has a polar flagellum. does not form spores;
In addition, Guhum staining was negative and showed no acid-fast properties.
(b)各種培地上での生育状態
28℃で培養し、1ないし14日間にわたって1硯祭し
た。(b) Growth status on various media The cells were cultured at 28° C. and cultured in one inkstone for 1 to 14 days.
■肉′tf基大平板培養=3日間培養で直径0.1ない
し0.5絹の円形1頭状、全光艮の集落を形成する。■ Meat'tf basic plate culture = After 3 days of culture, a colony of round, single-headed, full-light lilies with a diameter of 0.1 to 0.5 silk is formed.
表面は平滑、不透明、うすい黄土色を呈する。拡散性色
素は生成しない。The surface is smooth, opaque, and has a pale ocher color. No diffusible dye is produced.
■肉汁寒天斜面培養:中程度の糸状の生育を示し、不透
明、うすい黄土色を呈する。■Juice agar slant culture: Shows medium filamentous growth, is opaque, and has a pale ocher color.
■肉汁液体培、ij、 、混湧状に生青し、小爪の沈V
笈を生じ、菌1簡全形成しない。■ Meat juice liquid culture, ij, , raw green in a mixed well, small nail sink V
No bacteria are formed at all.
■肉tトセフチン響ジ・・j培グ3・ゼラヅーンを液化
しない。■ Meat t Tosefchin Hibikiji...j Cultivation 3. Do not liquefy Zeladun.
■リトマヌ・ミルり:ベプI・ンイhしない。■ Ritmanu Miruri: Bepu I Nyih not.
(c)生理的性質
■硝酸塩の迭尤; bt’8j計
(り脱窒反応::一志注
■MR(メチルレッド)テスト・[食性■vP(フオー
ゲ7験〕゛ロヌカウエルンテヌト二薗性
■インドールの生成:酩注
(′0硫化水素の生成冒陰性
■デンプンのカニ]水分j’f:’ : ’j’;、’
j j生(、紳クエン酸の利用:陽性
(のf!41泥窒累源の利用
I)硝酸カリウム;陽性
■)硫酸アンモニウム:υ−一
[相]色素の生成:うすいピンク色の拡散性色素を生成
する。(c) Physiological properties ■ Nitrate loss; bt'8j meter (denitrification reaction: Kazushi's note ■ MR (methyl red) test, [feedability ■ vP (Vouge 7 experiment) ■ Formation of indole: Intoxication ('0 Generation of hydrogen sulfide - starch crab) Moisture j'f:' : 'j';,'
j j Raw (, Utilization of citric acid: Positive (f! 41 Utilization of mud nitrogen sources I) Potassium nitrate; Positive ■) Ammonium sulfate: υ-1 [phase] Formation of pigment: Pale pink diffusible pigment generate.
qリウレアーゼ:陽性
0オキシダーゼ:陽性
[相]カタラーゼ:陽性(弱い)
■生育の範囲
T) pH:pH4,0〜7.0で生育するが、最適p
Hは4.6〜5.5゜
11)2詰度:14〜34℃で生育するが最適温度は2
8〜34℃。q Liurease: Positive 0 Oxidase: Positive [Phase] Catalase: Positive (weak) ■Growth range T) pH: Grows at pH 4.0 to 7.0, but optimum pH
H is 4.6-5.5° 11) 2 degree of clogging: grows at 14-34°C, but the optimum temperature is 2
8-34℃.
(0酸緊に刻する態度:好気的
(1Ω0−F(オキシダティブーファーメンタテイブ)
テスト〔ヒユー・レイフソン (Hugh・Leifs
on)法〕:酸化的
@潰からの酸およびガスの生成:
酸 ガス
L−アラビノース − −D−キシロース
− −
D−グルコース 士 −
D−マンノース ± −
D−フラクトース −−
D−ガラクトース + −α々 ガ
ス
麦 芽 才j+j −一
シ ョ ゛和、4
十 −乳
]唐 −−トレハロース
−−
D −ソ ル ビ ッ 1・
−−D−マンニット −−
イ ノ シ ッ ト
−−グ リ セ リ ン
−−デ ン ブ ン
− −以」−の菌学的性質を
4]するuK−+521株をバーシーズ・マニュアル・
オブ・デクーミナテイブ・バクテリオロジ−(Berg
ey’s Manua工OfDeterminati
ve Bacteriology )第8版の記求注
がないことから、スピリルムj萬和1菌と同定し、UK
−1521mをヌピリルム・エヌピー UK−1521
株(Spirillum sp、 UK−1521)と
命名した。(Attitude to be carved into 0 acid tension: aerobic (1Ω0-F (oxidative bufermentative)
Test (Hugh Leifs)
on) method]: Production of acids and gases from oxidative crushing: Acid Gas L-arabinose − −D-xylose − − D-glucose − D-mannose ± − D-fructose − − D-galactose + −α Gas malt sai j + j - one shot ゛wa, 4
10 - Breasts
] Tang ---Trehalose
--D-sol bit 1・
--D-Mannit --- Inosit
−−Glycerin
--Den Bun
- The uK-+521 strain, which has the following mycological properties, was obtained using the Bersey's Manual
Of Decuminative Bacteriology (Berg)
ey's Manua EngineeringOfDeterminati
ve Bacteriology) Since there is no annotation in the 8th edition, it was identified as Spirillum jmanwa 1 bacterium.
-1521m by Nupirilum NP UK-1521
The strain was named Spirillum sp, UK-1521.
なお、本菌株UK−1521株は、昭和58年5月6日
から通商産業省工業技術院微生物工業技術研究所(FB
I)K受託番号FEB、M P−7075として、ま
た昭和58年2月9日から財団法人発酵研究所にIFO
14227としてそれぞれ寄託されている。In addition, this strain UK-1521 has been used since May 6, 1981 by the Institute of Microbial Technology, Agency of Industrial Science and Technology, Ministry of International Trade and Industry (FB).
I) K accession number FEB, MP-7075, and IFO to Fermentation Research Institute from February 9, 1988.
14227, respectively.
本発明に用いられるスピリルム属細菌は一般にその性状
が変化しやすく、たとえば紫外線、X線。The properties of the Spirillum bacteria used in the present invention are generally susceptible to changes, such as exposure to ultraviolet rays and X-rays.
化学5JijH品(例、ニトロソグアニジン、エチルメ
タンスルホン酸)などを用いる人工父異手段で容易に変
異しうるものであり、どの様な変異株であっても本発明
の対象とするTAN−458の生産能全有するものはす
べて本発明に使用することができる。It can be easily mutated by artificial alienation methods using chemical products (e.g., nitrosoguanidine, ethyl methanesulfonic acid), etc., and any mutant strain of TAN-458, which is the subject of the present invention, is Anything with full production capacity can be used in the present invention.
TA N −458生産菌の培養に際しては、炭素源と
しては、たとえばグルコース、シュークロース、マルト
ース、屍糖蜜、グリセローμ、油脂類(例、大豆油、オ
リーブ油など)、有機酸類(例、クエン酸、コハク酸、
グルコン酸など)など菌が資化しうるものが適宜用いら
れる。窒素源とじてしては、たとえば大豆粉2幅火粉、
コーン・ヌティープ・リカー、乾)桑酵母、酵母エキス
、肉エキス・ペプトン・尿メモ、 ril、を酸アンモ
ニウム、硝酸アンモニウム jp化アンモニウム、リン
酸アンモニウムなどの有4に屋素化合物や無機硫黄化合
物が利用できる。また、勲椴塩としては、たとえば塩化
ナトリウム、塩化カリウム、炭酸力μシウム、硫酸マグ
ネシウム、リン酸−カリウム、リン酸二ナトリウムなど
の通常細菌の培う慎で必要な無機塩類が単独もしくは適
宜、組合せて使用される。When culturing TA N-458 producing bacteria, examples of carbon sources include glucose, sucrose, maltose, corpse molasses, glycerol μ, oils and fats (e.g. soybean oil, olive oil, etc.), organic acids (e.g. citric acid, succinic acid,
Gluconic acid, etc.) that can be assimilated by bacteria are used as appropriate. As a nitrogen source, for example, soybean powder,
Corn Nuteep Liquor, Dry) Mulberry yeast, yeast extract, meat extract, peptone, urine memo, ril, ammonium acid, ammonium nitrate, ammonium chloride, ammonium phosphate, etc. Compounds and inorganic sulfur compounds are used. can. In addition, Hunchu salt includes inorganic salts normally cultivated by bacteria, such as sodium chloride, potassium chloride, μsium carbonate, magnesium sulfate, potassium phosphate, and disodium phosphate, either singly or in appropriate combinations. used.
また、スビリ々ム属に、)%する抗生物質T A N
−458生産蘭の資化しうる硫黄化合吻、たとえば(克
酸塩(例、硫酸アンモニウムなど)、チオ伝6々塩(例
、チオ硫[俊アンモニウムなど)、亜(ゾ:C1俊塩(
例、亜硫酸アンモニウム)などの無機硫黄化合物+ 含
硫アミノ酸(例、シヌチン、システィン。In addition, antibiotics T A N
Assimilated sulfur compound proboscis of -458 production orchids, such as (kate salts (e.g., ammonium sulfate, etc.), thiodentagen salts (e.g., thiosulfate [ammonium, etc.),
Inorganic sulfur compounds such as ammonium sulfite) + sulfur-containing amino acids (e.g. synutin, cysteine).
L−チアゾリジン−4−カルボン1.IQ ) +ヒポ
タウリン、含の1fペプチド(例、グルタチオン)など
の有機硫黄化合物または、これらの混合物を培地に添加
すると目的物の生成量が増大する場合がある。L-thiazolidine-4-carvone 1. When organic sulfur compounds such as IQ)+hypotaurine, 1f peptides (eg, glutathione), or mixtures thereof are added to the medium, the amount of the target product produced may be increased.
また、硫酸第1鉄、硫e銅などの道金属類、ビタミンB
l 、ビオチンなどのビタミン類なども必要に応じて
添加される。さらにシリコーンオイルやポリアルキレン
グリコールエーテμなどの消泡剤や界面活性剤を培地に
添加してもよい。その細菌の発育を助け、TAN−45
8の生産を促進するような有根物や無機物を適宜に添加
してもよい。In addition, metals such as ferrous sulfate and copper sulfate, and vitamin B
Vitamins such as l, biotin, etc. are also added as necessary. Furthermore, antifoaming agents and surfactants such as silicone oil and polyalkylene glycol ether μ may be added to the medium. Helps the growth of bacteria, TAN-45
Rooted substances or inorganic substances that promote the production of No. 8 may be added as appropriate.
培養方法としては、一般の抗生物質の生産方法と同様に
行なえばよく、固体培養でも面体培養でもよい。液体培
養の場合は静置培養、撹拌培養。The culturing method may be the same as a general antibiotic production method, and solid culture or hedron culture may be used. For liquid culture, static culture and agitation culture are used.
振盈垢養9通気培養などいずれを実施してもよいがとく
に通気攪拌培養が好ましい。又培養温度はおよそ10し
〜35tEの範囲が好ましく、培地のpHは約4〜8の
範囲でおよそ8時間〜168時間、好ましくは24時間
〜144時間培養する。Although any method such as shaking and culturing may be carried out, aerated agitation culture is particularly preferred. The culture temperature is preferably in the range of about 10 to 35 tE, the pH of the medium is in the range of about 4 to 8, and the culture is carried out for about 8 to 168 hours, preferably 24 to 144 hours.
培養物から目的とする抗生物1TAN−458を採取す
るOては微生物の生産する代謝物をその微生物の培養物
から採取するのに通常使用される分は手段が適宜利用さ
れる。たとえばT A N−458は水溶性酸性物質で
、主としてP液中に含まれるので、−過または遠心分離
によって菌体を除去した後、その沖aから一般に有効物
質を分離、精製。To collect the target antibiotic 1TAN-458 from the culture, any means normally used to collect metabolites produced by microorganisms from the culture of the microorganisms may be used as appropriate. For example, TAN-458 is a water-soluble acidic substance and is mainly contained in the P solution, so after removing the bacterial cells by filtration or centrifugation, the effective substance is generally separated and purified from the aqueous solution.
採取する方法を用いる。すなわち適当な溶媒にAオン交
換クロマトグラフィー、分子ふるいクロマトグラフィー
あるいは減圧泪A6などの手段が単独あるいは任意の1
1旧序に組合わせて、または反復して用いられる。吸着
ハ:1としては活性炭、吸后性樹脂、陰イオン交倹1d
昭(アニオ:)型)、粉末セルロース、シリカゲルなど
が用いられ、あるいは分子ふるいなどの1生質全待った
担体も用いられる。Use the method of collecting. That is, A6-exchange chromatography, molecular sieve chromatography, vacuum chromatography, etc. may be used alone or in combination with an appropriate solvent.
Used in combination or repeatedly. Adsorption c: 1 is activated carbon, absorbent resin, anion exchanger 1d
Anio type), powdered cellulose, silica gel, etc. are used, or a single-organic carrier such as a molecular sieve is also used.
浴用溶媒は担体の[・≦−f1によって異なるがたとえ
ば水溶性#仕り溶媒、アセトン、メタノール、エタノー
ル、プロパツール、ブタノール、イソプロパノ−/し、
イソブクノールなどの含ゐくl各面Iあるいはアルカ!
J + 7,55 荊敲もしくは葡t;あるいは有機塩
の水溶r夜などが用いられる。The bathing solvent varies depending on the carrier [・≦−f1, but for example, water-soluble solvent, acetone, methanol, ethanol, propatool, butanol, isopropanol,
Contains such as isobuknol or alkaline!
J + 7,55 荊敲 or 葡 t; or aqueous organic salts are used.
さらに詳しく述べるならば、培養終了後培養液を遠心分
離し、灯体を除去する。当該物質が酸性物質であるため
、アニオン交換樹脂〔アンバーライト、工RA−400
,4,02,410(米国、ローム・アンド・ハース社
製)、ダウエックス−1(米国、ダウ・アンド・ケミカ
ル社製)、ダイヤイオン5A−21AおよびC(三菱化
成社製)〕などの01−またはACO−型が有利に利用
出来る。More specifically, after completion of the culture, the culture solution is centrifuged to remove the light body. Since the substance is an acidic substance, anion exchange resin [Amberlite, Engineering RA-400
, 4,02,410 (manufactured by Rohm and Haas, USA), DOWEX-1 (manufactured by Dow & Chemical, USA), Diaion 5A-21A and C (manufactured by Mitsubishi Kasei), etc. The 01- or ACO-type can be advantageously used.
吸着した当該物質の溶出液には食塩水または緩衝(41
を用い有効物質を溶出する。溶出液の脱塩には活性炭を
用いるクロマトグラフィーを行い、含水アルコ−/l/
等で溶出する。また希アンモニア水などを加えて中性な
いし微塩基性で溶出するとさらに良い結果が得られる。The eluate of the adsorbed substance is saline or buffer (41
The active substance is eluted using Chromatography using activated carbon was performed to desalt the eluate, and water-containing alcohol/l/
Elutes with etc. Further, even better results can be obtained by adding dilute ammonia water or the like to elute in neutral or slightly basic conditions.
有効物質の溶出液を減圧下泊緬し、濃縮液をアニオン交
換性分子ふるい樹脂、QAE−セファデックスA −2
5(cl型、ファルマシャ社製、スウェーデン)に吸着
させ、食塩水で溶出1分画する。活性区分を活性炭のク
ロマトグラフィーに付し、脱塩すると、化合物■のすt
llラムを含む溶液が得られる。また上記セファデック
スの代りに通常イオン・ペアード抽出法と称される方法
で濃縮液中の抗生物質を抽出することかできる。すなわ
ち、n個を夜中の有効成分を4級アpキ/L/(または
ベンジ/1/ )アンモニウムハライドを含むハロゲン
化炭化水素の溶液で抽出する。4殺アμキルアンモニウ
ムハフイドについてはたとえばトリーn−オクチル・メ
チル・アンモニウム・クロライド、n−ヘキサデシール
ベンジルジメチルアンモニウム・クロライド、テトラ−
n−ペンチルアンモニウム・ブロマイドなどが挙げられ
る。これらのアンモニウム塩は通常0.5〜6%の濃度
で用いられ、特に好ましくは1〜2%の濃度で用いられ
る。ハロゲン化炭化水素についてはたとえばメチレン・
ジクロライド、クロロフォアレムなどが溶剤として用い
られる。抽出液はアルカリ金属ハライド(例、ヨウ化ナ
トリウム、ヨウ化カリウム、臭化ナトリウム、臭化カリ
ウム)またはアルカリ土類金属ハライド(例、ヨウ化マ
グネシウム、ヨウ化亜鉛、ヨウ化カルシウム、臭化マグ
ネシウム、臭化カルシウム)を含む水溶液で処理される
と抗生物質は水溶液中にアルカリ金属塩またはアルカリ
土類金属塩として回収される。The eluate of the active substance was concentrated under reduced pressure, and the concentrated solution was treated with an anion exchange molecular sieve resin, QAE-Sephadex A-2.
5 (Cl type, manufactured by Pharmasha, Sweden), and eluted with saline and fractionated into one fraction. When the active fraction is subjected to activated carbon chromatography and desalted, the compound ■
A solution containing 11 rum is obtained. Furthermore, instead of using Sephadex, the antibiotic in the concentrate can be extracted by a method commonly called ion-paired extraction. That is, the active ingredients of the n active ingredients are extracted with a solution of halogenated hydrocarbon containing quaternary Apki/L/(or Bendi/1/) ammonium halide. For example, tri-n-octyl methyl ammonium chloride, n-hexadecylbenzyldimethyl ammonium chloride, tetra-
Examples include n-pentylammonium bromide. These ammonium salts are generally used in a concentration of 0.5 to 6%, particularly preferably 1 to 2%. Regarding halogenated hydrocarbons, for example, methylene
Dichloride, chlorophorem, etc. are used as solvents. The extract contains alkali metal halides (e.g., sodium iodide, potassium iodide, sodium bromide, potassium bromide) or alkaline earth metal halides (e.g., magnesium iodide, zinc iodide, calcium iodide, magnesium bromide, When treated with an aqueous solution containing calcium bromide), the antibiotic is recovered as an alkali metal salt or an alkaline earth metal salt in the aqueous solution.
アルカリ金属ハライドまたはアルカリ土類金属ハライド
の足は使用された四級アンモニウムハライドの1.1〜
2.0モル当量を用いれば良い。The alkali metal halide or alkaline earth metal halide foot is between 1.1 and 1.1 of the quaternary ammonium halide used.
2.0 molar equivalent may be used.
得られた水溶液を活性炭あるいは吸着性樹脂たとえばダ
イヤイオンHP−20(三菱化成社製)のクロマトグラ
フィに付し、脱塩すると、化合物■のアルカリ金属塩ま
たはアルカリ土類金属塩を含む溶液が得られる。以上述
べた方法などで抗生物質が未だ不純物を含む場合、いか
に述べろ方法が用いられる。すなわち、化合物Iを含む
水溶液はFA W(jされ、濃縮物は分取用高速液体ク
ロマトグラフィーに付され、さらに精製される。液体ク
ロマトグラフィーに用いられる担体としては逆層系の担
体たとえばTSKゲμ〔東洋曹達社製〕、YMCゲル〔
京都クロマト社製〕などが用いられる。The resulting aqueous solution is subjected to chromatography using activated carbon or an adsorbent resin such as Diaion HP-20 (manufactured by Mitsubishi Kasei Corporation) and desalted to obtain a solution containing the alkali metal salt or alkaline earth metal salt of compound (1). . If the antibiotic still contains impurities using the methods described above, the methods described above are used. That is, an aqueous solution containing Compound I is subjected to FAW (j), and the concentrate is subjected to preparative high-performance liquid chromatography for further purification. μ [manufactured by Toyo Soda Co., Ltd.], YMC gel [
[manufactured by Kyoto Chromato Co., Ltd.] etc. are used.
移動層としては通常イオン・ペアード法で用いられる試
薬たとえば水酸化テトラ−n−ブチルアンモニウム、リ
ン酸デトフーn−グチμアンモニウムなどを含む水溶液
が用いられる。分取画分は分析用高速液体クロマトグラ
フィーによって単一性カkN Bされ、シングルピーク
を示す両分が集められる。As the mobile phase, an aqueous solution containing reagents used in the ion-paired method, such as tetra-n-butylammonium hydroxide, detofu n-gutiammonium phosphate, etc., is used. The fractions are analyzed for uniformity by analytical high performance liquid chromatography, and both fractions showing a single peak are collected.
この画分中にヨウ化ナトリウムあるいは臭化ナトリウム
全加えると、化合物Iはナトリウム塩となる。得られた
溶液?活性炭のクロマトグラフィーに付し、脱塩後、溶
出液全滅圧下低温で製糊し、濃縮物にジエチルエーテル
などを加えると、粉末状の化合物■のナトリウム塩が得
られる。ただし、溶出液を濃縮し、7う糊液を厘rlJ
乾燥すると化合物工のナトリウム塩は直ちに仕打tする
。When all sodium iodide or sodium bromide is added to this fraction, Compound I becomes the sodium salt. The resulting solution? After subjecting to activated carbon chromatography and desalting, the eluate is made into a paste at low temperature under completely evaporated pressure, and diethyl ether or the like is added to the concentrate to obtain the powdered sodium salt of compound (1). However, the eluate should be concentrated and the glue solution should be
When dried, the sodium salt of the compound is immediately treated.
TAN−458の(−C遁式はT A 1q −458
ナトリウム2aと5Q2786o p−ニトロ・ベン
ジルエステル(SQ27860pIqnとν;各)の核
磁気共鳴スペクトル()i−N M B )を比較する
ことによって容易に確認される(表1)。TAN-458's (-C ton style is T A 1q -458
This is easily confirmed by comparing the nuclear magnetic resonance spectra ()i-NMB) of sodium 2a and 5Q2786o p-nitrobenzyl ester (SQ27860pIqn and ν; each) (Table 1).
(以下余白)
表1 δppm J(Hz)
※ W、L、 Parker et al、 J、 A
ntibiotics 35+653 (1982
)
また、TAN−458の不斉次素は1個であるが、絶対
配位については下式で表わされる既知カルバペネム系抗
生物質C−19393u2M2!と円二色性(CD)ス
ペクトlしを比較することによって容易に類推すること
が出来る。(Left below) Table 1 δppm J (Hz) * W, L, Parker et al, J, A
ntibiotics 35+653 (1982
) Also, TAN-458 has one asymmetric element, but the absolute coordination is expressed by the following formula, which is the known carbapenem antibiotic C-19393u2M2! It can be easily inferred by comparing the circular dichroism (CD) spectrum.
TI州−458C−19393H2142すなわち化合
物工のナトリウム塩のCDスペクトルにおいては〔θ〕
12°218 (−12,100)およ1n
び255(+7,510)に特徴的なコツトン効果全示
し、一方、C−+9393H2M2のそれにおいては〔
θ〕′12°230 (−27300)および253n
口
(+ 23100)LS、Haradaら+Tetra
hedron +39、 γ5 (+983))に
コツトン効果を示す。In the CD spectrum of TI state-458C-19393H2142, that is, the sodium salt of compound engineering, [θ]
12°218 (-12,100), 1n and 255 (+7,510) all exhibit the characteristic Kotton effect, while that of C-+9393H2M2 [
θ〕'12°230 (-27300) and 253n
Mouth (+23100) LS, Harada et al.+Tetra
hedron +39, γ5 (+983)) shows a trickling effect.
これらはetとんと同じCDスペクトル・パターンと、
(スわれるので、TAN−458の5位の絶対配位はI
?5であると推足される。These have the same CD spectrum pattern as eton,
(The absolute configuration of the 5th position of TAN-458 is I
? It is estimated that it is 5.
後述の実施例2で得られたTA xq −458ナトリ
ウム塩の物理化学的性状は以下の通りである。The physicochemical properties of TA xq-458 sodium salt obtained in Example 2 described below are as follows.
(1)形状;白色粉末状物質
(2)分子式(分子量) i C7H6N03Na(1
75,12)(3)紫外線吸収スペクト)v(水中)を
入 253±2nm(Fi1% =156
ンmaX l!(4)
赤外部吸収スペクトyv<食塩板上)、主要ピー り
(l:17!−1) 二 3450. 2960.
1750゜+580.1410.1340.1290
.1260゜1190.1130.1050,1020
,950゜895、 840. 800. 780.
750゜710、 660
(5)1H−117MI’lスペクトN (400’
Hz 、D 20中)(δppmJ(H,) 6.2
9(IH,t、J=2.6.H2)。(1) Shape: White powdery substance (2) Molecular formula (molecular weight) i C7H6N03Na (1
75,12) (3) Ultraviolet absorption spectrum) Enter v (in water) 253 ± 2 nm (Fi1% = 156
NmaX l! (4)
Infrared absorption spectrum yv<on salt plate), main peak
(l:17!-1) Two 3450. 2960.
1750°+580.1410.1340.1290
.. 1260°1190.1130.1050,1020
,950°895, 840. 800. 780.
750°710, 660 (5) 1H-117MI'l Spect N (400'
Hz, D20) (δppmJ(H,) 6.2
9 (IH, t, J=2.6.H2).
4.30(lH5m、 H5)、3.46(IH,dd
、J−5,4゜16.8. H6a)、 3.04(I
H,dd、 J=2−9.16.8゜H6b)、2−9
0(IH,dda、 J=18.8.2.6,9.6゜
Ja) 、2.77(IL add、J=18.8.2
.6.8.4゜Hlb)
(6) CDスペクトル(水中);
〔θ〕nm 218(−12,100)および〔θ)
255(+ 7,510)m
(7) i6 Mクロマトグラフィー〔セルロースf
2f41 。4.30 (IH5m, H5), 3.46 (IH, dd
, J-5,4゜16.8. H6a), 3.04(I
H, dd, J=2-9.16.8°H6b), 2-9
0 (IH, dda, J = 18.8.2.6, 9.6°Ja), 2.77 (IL add, J = 18.8.2
.. 6.8.4°Hlb) (6) CD spectrum (in water); [θ] nm 218 (-12,100) and [θ)
255 (+ 7,510) m (7) i6 M chromatography [cellulose f
2f41.
(来光化成社製)]
溶媒系 Efn−プロパ
ツール:水(4:1) 0.46(
8)高速液体クロマトグラフィー(ウォーターヌ社製、
米国)1.l!、ii体、マイクロボンダパックC,,
、移動層、0.0057Aテトラ−n−1チルアンモニ
ウムハイI゛ロキザイド10.02)Δリンt’j?
M衝M (pH7,8) 、 2 qi / min
Rt(min)=8.5
(9)溶解性:水、ジメチルヌμフォキサイドなどに易
溶。(manufactured by Raiko Kasei Co., Ltd.)] Solvent system Efn-propertool: water (4:1) 0.46 (
8) High performance liquid chromatography (manufactured by Waterne,
USA) 1. l! , ii body, Micro Bonder Pack C,,
, mobile phase, 0.0057A tetra-n-1 tylammonium high I゛loxide 10.02) Δphosphorus t'j?
M concentration (pH 7,8), 2 qi/min
Rt (min) = 8.5 (9) Solubility: Easily soluble in water, dimethyl nufoxide, etc.
00安定性:溶(包中では、pH5以−[の水浴顛およ
びメタノール中で直ちに分解、賑アルカリ注水溶液(p
H7,5〜9)中ではかなシ安定。00 Stability: Decomposes immediately in a water bath with a pH of 5 or higher and in methanol in a solution (in a package)
H7, 5-9) It is stable in the middle.
次にTAN−458の生物学的性状について述べる。T
A N−458すtlヮム塩の各種饋生物に対する抗
助スペクトルは!:Ffj2表に示すとおシである。こ
の表から明らかなようにTAN−458はダラム陽性閉
、ダラム陰性しゴに有効でちる。Next, the biological properties of TAN-458 will be described. T
What is the anti-inflammatory spectrum of A N-458 STLM salt against various feeding organisms? : It is recommended to show it in the Ffj2 table. As is clear from this table, TAN-458 is effective against Durham-positive and Durham-negative cases.
ト ■ 0 Φ 自 へ ■ 0 ヘ
トー ■ の O■ の −
さ1 ω(’l’) COCo C)
0 へ N ■ O■へへω
へ■ N寸
本発明によって得られるTAN−458は上記のデータ
から明らかなようにダラム陽性菌、ダラム陰性菌などの
轍生物に対して強い生育阻止作用を示す。それ故に、T
AN−458はヒトおよび家畜(例、ウシ、ゲタ、ニワ
トリ)などのNI菌感染症において殺菌剤として用いる
ことが出来る。■ 0 Φ self to ■ 0 he to ■ of O■ of -
Sa1 ω('l') COCo C)
0 to N ■ O■ to ω
As is clear from the above data, TAN-458 obtained by the present invention exhibits a strong growth-inhibiting effect on rutting organisms such as Durum-positive bacteria and Durum-negative bacteria. Therefore, T
AN-458 can be used as a fungicide in the treatment of NI bacterial infections in humans and livestock (eg, cows, geese, chickens), etc.
TAN−458をたとえば大腸菌感染症の治療薬として
用いるには、たとえばTAN−458ナトリウム塩全生
理的食塩水に溶解して注射剤として非経口的に皮下また
は筋内内に1〜l OOlng/ kq/日、好1しく
は5〜501197にり7日投与する。To use TAN-458 as a therapeutic agent for E. coli infection, for example, TAN-458 sodium salt can be dissolved in total physiological saline and administered parenterally subcutaneously or intramuscularly as an injection at 1 to 1 OOlng/kq. /day, preferably 5 to 501197 days for 7 days.
また経口剤として、rAy−458を乳糖と混合してカ
プセル剤とし、TAN−458として1〜1001′!
g/ kq /日、好ましくは5〜50■/ kg/日
投与する。In addition, as an oral preparation, rAy-458 is mixed with lactose to form a capsule, and TAN-458 is prepared from 1 to 1001'!
g/kq/day, preferably 5-50 kg/kg/day.
また、TAN−458は新しい医薬の合成中間体あるい
は試夢としても極めて有望な化合物である。Furthermore, TAN-458 is an extremely promising compound as a synthetic intermediate for new medicines or as a dream come true.
次に突施例をもってさらに詳細に本発明の詳細な説明す
るか、これによって本発明が限定されるものではない。Next, the present invention will be explained in more detail with reference to specific examples, but the present invention is not limited thereto.
バーセン1−は、特にことわ9のないかぎシ爪J資/容
Iit%を示す。Basen 1- indicates claw J capital/volume Iit% without particular mention.
実施例1
栄養寒天斜mi上に生育させたスピリルム・エスピーU
K −1521(、FERM P−7Q75 、
工FO14227)株全、グルコース2%、可溶性ζ
5隻粉3%、ソイビーン・フラワー1%、コーン・ヌテ
ィープ・リカー1%、ポリペプトン(大玉栄養化学社製
)0,5%、食トム0.3%、沈tfi性炭酸カルシウ
ム0.3%(pH6,5)からなる培地40rntを含
む200*を容エルレン・マイヤー・フラスコ7本に接
種して、24℃で48時間培養しその培養物をね(菌と
した。次にグルコース3%、可溶性鍼粉3%、プロフロ
(ブロククー・アンド・ギャンブル社製)1.5%、ソ
イ・ビーン・ミーtv l、 5%、塩化コバルト2p
pm (pH6,5)からなる培地4Otzlを含む2
00vl容工μレン・マイヤー・フラスコ250本K、
nj+ g種rHヲl ct ツツ接11 L、17℃
で3日間4フ・又酋坑養を行なった。この培養物を抵温
で遠心分離し、上清蔽約7.5eをえた。Example 1 Spirillum sp. U grown on nutrient agar slant mi
K-1521 (, FERM P-7Q75,
FO14227) strain, glucose 2%, soluble ζ
5 star flour 3%, soybean flour 1%, corn nutip liquor 1%, polypeptone (manufactured by Otama Nutritional Chemical Co., Ltd.) 0.5%, dietary tom 0.3%, precipitated TFI calcium carbonate 0.3% ( Seven Erlen-Meyer flasks were inoculated with 200 * containing 40 rnt of a medium consisting of 3% glucose (pH 6.5) and cultured at 24°C for 48 hours. Acupuncture powder 3%, Proflo (manufactured by Brokku & Gamble) 1.5%, Soy Bean Meat TV 1, 5%, cobalt chloride 2p
pm (pH 6,5) containing 2 Otzl
00vl Mulen Meyer flask 250 bottles K,
nj+ g type rHol ct Tutu connection 11 L, 17℃
We carried out 4-f/mata-mine cultivation for 3 days. The culture was centrifuged at low temperature to yield a supernatant of approximately 7.5e.
上滑液にアセトン<30g)全加え、攪拌、濾過して得
られたアセトン抽出液を濃縮、濃縮岐(71)をダウエ
ックスI X 2 (ci−型)(200rsl )の
カラムクロマトグツフィーに付した。有効区分を012
J直食塩水で溶出し、pl、5に補正後、アラかじめ希
アンモニア水で処理した活性炭(400d )のカラム
に調製g!を通し、水および20%メクノール水で溶出
分画した。溶出液を濃+li’4 L、l1廂1夜(7
50gl)を2%トリーn−オクチルメチルアンモニウ
ム クロライド/メチレンクロライド溶液で抽出し、メ
チレンクロライド抽出MTh1.5%ヨウ化ナトリウム
水(50Or+J)で再抽出した。Add all acetone (<30 g) to the supernatant synovial fluid, stir, and filtrate. Concentrate the obtained acetone extract and transfer the concentrated branch (71) to column chromatography using DOWEX IX2 (ci-type) (200 rsl). Attached. Valid category is 012
Elute with J saline, correct to pl, 5, and prepare on a column of activated carbon (400 d) that has been pretreated with dilute ammonia water. The mixture was eluted and fractionated with water and 20% Meknol water. The eluate was concentrated +li'4 L, 1 night (7
50gl) was extracted with 2% tri-n-octylmethylammonium chloride/methylene chloride solution and re-extracted with methylene chloride extracted MTh1.5% sodium iodide aqueous solution (50Or+J).
抽出八属KpH8に調整し、調整液を前記と同様に調整
した活性炭(150ml)のカラムクロマトグラフィー
に何した。水で溶出された両分を分析用HPLCに付し
、単一ピークを示す画分を低温下減圧蒸留し、油状の工
のナトリウム塩(3C1’)を得た。The pH of the extract was adjusted to 8, and the adjusted solution was subjected to column chromatography using activated carbon (150 ml) prepared in the same manner as above. Both fractions eluted with water were subjected to analytical HPLC, and the fraction showing a single peak was distilled under reduced pressure at low temperature to obtain an oily sodium salt (3C1').
実施例2
大/lと例1と同様の朱件で培か、はれた培碧面のが(
心上清液(3,5g)をi2L”、a例1と同様の方法
で処理し、1回目の活1・士疾クロマ1−グラフィーの
溶出液全QAE−セフ1デックスA−25(CI 型
。Example 2 A swollen cultured green surface was cultivated with large / l and the same vermilion as in Example 1 (
Cardiac supernatant fluid (3.5 g) was treated with i2L'' in the same manner as in Example 1, and the eluate of the first active chroma 1-graph total QAE-Sef1Dex A-25 (CI Type.
ファルマンア社鯛、スウェーデン)(50yt)のカラ
ムクロマトグラフィーに付した。抗生物質をQ、 l
M食塩水で溶出5分両した。有効IZ分(45yt )
を活性mのクロマトグラフィー(50elに付し、水で
溶出9分画した。イア効N分(96ytのl梅歪1!j
JYりをTSK−ゲル(厨n仁舒込工莢半」」罎)を
ゼユ体とする分取用高速液1本クロマトグラフィーに−
付し、0.005Mテトラグチルアンモニウムハイドロ
キサイド/ 0.02 yhリンle’Lj i2J’
ttIIJ液(pH7,8)で溶出した。有効区分(5
5ゴ)甲にヨウ化ナトリウム(41’V)を・加え、水
溶液を活性炭のクロマトグラフィーに付した。1拝出蔽
を低温下減圧蒸留、′jし、7j:J 4’l’f物中
にジエチルエーテルを加えると化合!!2フエのナトリ
ウム塩(22・・y)が吸湿性のわJ木として?鰺られ
た。The mixture was subjected to column chromatography using Farmana Co., Ltd. (Tai, Sweden) (50 yt). Antibiotics Q, l
Elution was continued for 5 minutes with M saline. Effective IZ minute (45yt)
was subjected to active m chromatography (50 el, and 9 fractions were eluted with water.
For preparative high-performance liquid single-bottle chromatography using JY-ri as TSK-gel (Chuunrenshugomekogohan') as Zeyu-body.
Attached, 0.005M tetragutylammonium hydroxide / 0.02 yh phosphorus le'Lj i2J'
It was eluted with ttIIJ solution (pH 7, 8). Valid category (5
5) Sodium iodide (41'V) was added to the instep, and the aqueous solution was subjected to activated carbon chromatography. 1) Distill the mixture under reduced pressure at low temperature, and then add diethyl ether to the 7j:J 4'l'f product and it will combine! ! Is the sodium salt of 2Fe (22...y) a hygroscopic tree? I was bitten.
パs + imはT/覧N−458ナトリウム塩の赤外
部吸収スペクトル(食塩板上)を、第2図は H−)I
↑lRスペクトル(400MH2,量水中)をそれぞれ
示す。Pass + im is the infrared absorption spectrum (on a salt plate) of T/view N-458 sodium salt, and Figure 2 is H-) I
↑1R spectra (400MH2, volumetric water) are shown.
Claims (1)
上式の化合物を生成蓄積せしめ、これを採取することを
特徴とする上式の化合物またはその塩の製造法。[Scope of Claims] A compound of the above formula, which is characterized by culturing in a whole culture medium a microorganism producing a compound of the formula belonging to the genus Spirillum, producing and accumulating the compound of the above formula in the culture, and collecting the compound. or the method of manufacturing the salt.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP58086182A JPS59210897A (en) | 1983-05-16 | 1983-05-16 | Production of beta-lactam compound |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP58086182A JPS59210897A (en) | 1983-05-16 | 1983-05-16 | Production of beta-lactam compound |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JPS59210897A true JPS59210897A (en) | 1984-11-29 |
Family
ID=13879618
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP58086182A Pending JPS59210897A (en) | 1983-05-16 | 1983-05-16 | Production of beta-lactam compound |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS59210897A (en) |
-
1983
- 1983-05-16 JP JP58086182A patent/JPS59210897A/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2873340B2 (en) | Antibiotic TAN-1057, its production method and use | |
| FR2517697A1 (en) | NOVEL ANTIBIOTIC AMINOGLYCOSIDES CALLED SACCHAROCINES AND THEIR PRODUCTION | |
| HU181721B (en) | Process for preparing antibiotics c-19393sdown 2 and c-1939hdown 2 | |
| JPS59210897A (en) | Production of beta-lactam compound | |
| JPS6261037B2 (en) | ||
| US4656288A (en) | Antibiotics, their production and use | |
| US4521340A (en) | Pharmaceutically acceptable salts of the antibiotic C-19393 E5 | |
| JPH0120153B2 (en) | ||
| JP2913101B2 (en) | Antibiotic TAN-1171 and method for producing the same | |
| JPS5831196B2 (en) | SF-1771 Bushitsuno Seizouhou | |
| JPH0582398B2 (en) | ||
| FR2463618A1 (en) | NOVEL ANTIBIOTIC AMINOGLYCOSIDE AND ITS PRODUCTION | |
| JPS589676B2 (en) | Nojirimycin B | |
| JPH09157266A (en) | Novel antibiotics, epoxyquinomycins A and B, and method for producing the same | |
| KR830000618B1 (en) | Preparation method of new antibiotic SF-2050B | |
| JPH0439477B2 (en) | ||
| WO1986005185A1 (en) | Antibiotic, process for its preparation, and microorganism | |
| JPS6046958B2 (en) | New antibiotic SF-2049 substance and its manufacturing method | |
| JPH08217760A (en) | New antibiotic B-4607A | |
| JPS596891A (en) | Antibiotic substance y-18055 and preparation thereof | |
| JPH0629227B2 (en) | D-beta-lysylmethanediamine and method for producing the same | |
| JPH08208658A (en) | New compound thiomarinol d, e and f | |
| JPH0578355A (en) | B-1015 compound | |
| JPH0571234B2 (en) | ||
| JPH02306985A (en) | Antibiotic om-5689a1 and a2 and production thereof |